@article{2951124,
    title = "864 Intravenous (IV) vinorelbine (VRL) plus hormone therapy (HT) versus hormone therapy alone in hormone-refractory prostate cancer (HRPC). Final report of a randomised phase III study",
    author = "Abratt, RP and Brune, D and Dimopoulos, MA and Kliment, J and Breza, J and Selvaggi, P and Beuzeboc, P and Demkow, T and Oudard, S",
    journal = "EJC supplements",
    year = "2003",
    volume = "5",
    number = "1",
    pages = "S260"
}